01 1Laboratorios Imperiales, S.A. de C.V.
01 1Bismuth Tribromophenate
01 1Mexico
NDC Package Code : 57465-152
Start Marketing Date : 2015-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Bismuth Tribromophenate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bismuth Tribromophenate, including repackagers and relabelers. The FDA regulates Bismuth Tribromophenate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bismuth Tribromophenate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bismuth Tribromophenate supplier is an individual or a company that provides Bismuth Tribromophenate active pharmaceutical ingredient (API) or Bismuth Tribromophenate finished formulations upon request. The Bismuth Tribromophenate suppliers may include Bismuth Tribromophenate API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bismuth Tribromophenate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bismuth Tribromophenate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bismuth Tribromophenate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bismuth Tribromophenate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bismuth Tribromophenate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bismuth Tribromophenate suppliers with NDC on PharmaCompass.
We have 1 companies offering Bismuth Tribromophenate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?